Arcadia Investment Management Corp Amgen Inc Transaction History

Arcadia Investment Management Corp

$606 Million
Q3 2024

A detailed history of Arcadia Investment Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Arcadia Investment Management Corp holds 175 shares of AMGN stock, worth $45,963. This represents 0.01% of its overall portfolio holdings.

Number of Shares

175

Previous 175 -0.0%

Holding current value

$45,963

Previous $54,000 3.7%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $430,460 - $519,620	-1,601 Reduced 90.15%	175 $49,000
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $9,460 - $10,673	-37 Reduced 2.04%	1,776 $511,000
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $167,987 - $198,642	-784 Reduced 30.19%	1,813 $402,000
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $662,693 - $807,712	-2,935 Reduced 53.05%	2,597 $627,000
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $287,661 - $365,508	1,256 Added 29.37%	5,532 $1.45 Million
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $13,018 - $14,682	58 Added 1.38%	4,276 $964,000
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $525,557 - $584,853	2,278 Added 117.42%	4,218 $1.03 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $61,834 - $68,404	-282 Reduced 12.69%	1,940 $469,000
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $611,556 - $699,870	-3,075 Reduced 58.05%	2,222 $500,000
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $15,283 - $17,906	72 Added 1.38%	5,297 $1.13 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $286,369 - $317,705	1,226 Added 30.66%	5,225 $1.27 Million
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $172,867 - $201,449	779 Added 24.19%	3,999 $995,000
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $54,095 - $64,417	-250 Reduced 7.2%	3,220 $740,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $14,079 - $15,657	60 Added 1.76%	3,470 $882,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $119,675 - $146,857	605 Added 21.57%	3,410 $804,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $26,424 - $35,046	-145 Reduced 4.92%	2,805 $569,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $70,953 - $91,200	375 Added 14.56%	2,950 $711,000
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $411,770 - $493,386	2,365 Added 1126.19%	2,575 $498,000
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $41,924 - $48,938	-235 Reduced 52.81%	210 $41,000
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $7,411 - $8,355	40 Added 9.88%	445 $92,000
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $24,907 - $27,976	150 Added 58.82%	405 $75,000
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $10,971 - $12,258	-65 Reduced 20.31%	255 $44,000
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $53,532 - $61,120	320	320 $60,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.

Account

Arcadia Investment Management Corp Amgen Inc Transaction History